Laurent Alberti

2.8k total citations · 1 hit paper
48 papers, 1.9k citations indexed

About

Laurent Alberti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Laurent Alberti has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 13 papers in Gastroenterology. Recurrent topics in Laurent Alberti's work include Sarcoma Diagnosis and Treatment (23 papers), Gastrointestinal Tumor Research and Treatment (13 papers) and Immunotherapy and Immune Responses (6 papers). Laurent Alberti is often cited by papers focused on Sarcoma Diagnosis and Treatment (23 papers), Gastrointestinal Tumor Research and Treatment (13 papers) and Immunotherapy and Immune Responses (6 papers). Laurent Alberti collaborates with scholars based in France, United States and Canada. Laurent Alberti's co-authors include Jean‐Yves Blay, Anne‐Valérie Decouvelaere, Daniel Pissaloux, Isabelle Ray‐Coquard, Dominique Ranchère‐Vince, Adeline Duc, Philippe A. Cassier, Dominique Ranchère, Jean‐Yves Scoazec and Pierre‐Paul Bringuier and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Laurent Alberti

45 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

2011 382 citations Françoise Ducimetière, A. Lurkin et al. PLoS ONE profile →

Peers

Countries citing papers authored by Laurent Alberti

Since Specialization

Citations

This map shows the geographic impact of Laurent Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Alberti more than expected).

Fields of papers citing papers by Laurent Alberti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Alberti. The network helps show where Laurent Alberti may publish in the future.

Co-authorship network of co-authors of Laurent Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Alberti. A scholar is included among the top collaborators of Laurent Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Alberti. Laurent Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients	Cancer Management and Research	Stefania Benini, Gabriella Gamberi et al.	31
2	Atypical cutaneous melanocytic tumours arising in two patients with Li–Fraumeni syndrome	Pathology	Daniel Pissaloux, Laurent Alberti et al.	5
3	Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study	The Lancet Oncology	Antoîne Italiano, Gaëlle Pierron et al.	118
4	KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome	BMC Cancer	Mehdi Brahmi, Laurent Alberti et al.	13
5	A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage	OncoImmunology	Colette Dezutter‐Dambuyant, Isabelle Durand et al.	74
6	Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology	BMC Cancer	Armelle Dufresne, Laurent Alberti et al.	15
7	Impact of Molecular Analysis on the Final Sarcoma Diagnosis	The American Journal of Surgical Pathology	Agnès Neuville, Dominique Ranchère‐Vince et al.	43
8	Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas	Targeted Oncology	Daniel Pissaloux, Laurent Alberti et al.	9
9	Gene Expression Patterns of Hemizygous and Heterozygous KIT Mutations Suggest Distinct Oncogenic Pathways: A Study in NIH3T3 Cell Lines and GIST Samples	PLoS ONE	Jean‐Baptiste Bachet, Séverine Tabone‐Eglinger et al.	11
10	Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas	European Journal of Cancer	Emmanuel Watkin, Laurent Alberti et al.	92
11	Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing breakdown →	PLoS ONE	Françoise Ducimetière, A. Lurkin et al.	382
12	Therapeutic pipeline for soft-tissue sarcoma	Expert Opinion on Pharmacotherapy	Philippe A. Cassier, Sana Intidhar Labidi‐Galy et al.	6
13	Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution	Anti-Cancer Drugs	Jérôme Fayette, Helen Boyle et al.	22
14	In vitro sonodynamic cytotoxicity in regulated cavitation conditions	Ultrasonics	Jean-Christophe Béra, Laurent Alberti et al.	20
15	Assay of hydroxyl radicals generated by focused ultrasound	Ultrasonics Sonochemistry	Laurent Villeneuve, Laurent Alberti et al.	78
16	Emerging drugs for the treatment of soft tissue sarcomas	Expert Opinion on Emerging Drugs	Philippe A. Cassier, Armelle Dufresne et al.	6
17	ET-743: a novel agent with activity in soft-tissue sarcomas	Current Opinion in Oncology	Jérôme Fayette, Isabelle Ray Coquard et al.	55
18	Targeted cancer therapies.	PubMed	Jean‐Yves Blay, Axel Le Cesne et al.	31
19	Lack of Antitumor Activity of Recombinant Endostatin in a Human Neuroblastoma Xenograft Model	Journal of Neuro-Oncology	Emmanuel Jouanneau, Laurent Alberti et al.	32
20	A kit of human polyclonal IgG for the diagnosis of infectious processes	Journal of Radioanalytical and Nuclear Chemistry	Carlos Pérez, Tomás Antônio Moreira et al.	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact